PE20121347A1 - Gel blando adhesivo para tratar aves de corral - Google Patents

Gel blando adhesivo para tratar aves de corral

Info

Publication number
PE20121347A1
PE20121347A1 PE2012000121A PE2012000121A PE20121347A1 PE 20121347 A1 PE20121347 A1 PE 20121347A1 PE 2012000121 A PE2012000121 A PE 2012000121A PE 2012000121 A PE2012000121 A PE 2012000121A PE 20121347 A1 PE20121347 A1 PE 20121347A1
Authority
PE
Peru
Prior art keywords
gum
adhesive
soft
gel
adhesive gel
Prior art date
Application number
PE2012000121A
Other languages
English (en)
Inventor
Eng-Hong Lee
Original Assignee
Vetech Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetech Lab Inc filed Critical Vetech Lab Inc
Publication of PE20121347A1 publication Critical patent/PE20121347A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

REFERIDA A UNA MEZCLA EN FORMA DE POLVO SECO QUE COMPRENDE: a) UNA GOMA ADHESIVA TAL COMO GOMA XANTANA, GOMA GUAR, GOMA ARABIGA O GOMA DE HABA DE LANGOSTA, b) CARRAGENANO Y c) MALTODEXTRINA, DONDE DICHA MEZCLA SE SUSPENDE EN AGUA PARA FORMAR UN GEL FLUIDO, BLANDO Y ADHESIVO. TAMBIEN ESTA REFERIDA A UNA COMPOSICION EN FORMA DE GEL, FLUIDO, BLANDO Y ADHESIVO QUE COMPRENDE: a) GOMA XANTANA EN UNA CANTIDAD DE ENTRE 0,05% Y 0,15% P/V, b) CARRAGENANO, c) AGUA Y d) UN AGENTE TERAPEUTICO SELECCIONADO DE i) UN ORGANISMO VIVO TAL COMO EL VIRUS DE LA ENTERITIS HEMORRAGICA, VIRUS DE LA ENFERMEDAD DE NEW CASTLE, SALMONELLA, NEUMOVIRUS, ENTRE OTROS, ii) UNA VITAMINA, iii) UN MINERAL Y iv) UN ELECTROLITO. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE AVES DE CORRAL EN CORRALES O GRANJAS ABIERTAS O CRIADEROS
PE2012000121A 2009-07-28 2010-07-27 Gel blando adhesivo para tratar aves de corral PE20121347A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51092609A 2009-07-28 2009-07-28
CA2674143 2009-07-28

Publications (1)

Publication Number Publication Date
PE20121347A1 true PE20121347A1 (es) 2012-10-26

Family

ID=43528666

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012000121A PE20121347A1 (es) 2009-07-28 2010-07-27 Gel blando adhesivo para tratar aves de corral

Country Status (14)

Country Link
US (1) US8900623B2 (es)
EP (1) EP2459222B1 (es)
CN (1) CN102481371B (es)
BR (1) BR112012001938B1 (es)
CA (1) CA2769223C (es)
EA (1) EA024592B1 (es)
EG (1) EG26998A (es)
ES (1) ES2628452T3 (es)
HU (1) HUE033213T2 (es)
PE (1) PE20121347A1 (es)
PL (1) PL2459222T3 (es)
PT (1) PT2459222T (es)
WO (1) WO2011011873A1 (es)
ZA (1) ZA201201009B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2464522C (en) 2004-04-15 2011-11-15 Eng-Hong Lee Soft gel delivery system for treating poultry
CN103689288B (zh) * 2013-12-20 2015-07-22 大连赛姆生物工程技术有限公司 一种羊自主采食型植物源复合药效营养品及其制备方法
CN103689228B (zh) * 2013-12-20 2015-07-22 大连赛姆生物工程技术有限公司 一种猪自主采食型植物源复合药效营养品及其制备方法
CN103704522B (zh) * 2013-12-20 2015-12-09 大连赛姆生物工程技术有限公司 一种鸡自主采食型植物源复合药效营养品及其制备方法
CN103704520B (zh) * 2013-12-20 2016-03-16 大连赛姆生物工程技术有限公司 一种鸭自主采食型植物源复合药效营养品及其制备方法
CN103734520B (zh) * 2013-12-20 2015-07-22 大连赛姆生物工程技术有限公司 一种马自主采食型植物源复合药效营养品及其制备方法
CN103704521B (zh) * 2013-12-20 2016-03-09 大连赛姆生物工程技术有限公司 一种牛自主采食型植物源复合药效营养品及其制备方法
CN106063523A (zh) * 2015-04-20 2016-11-02 上海绿奥生物科技有限公司 促进南美白对虾生长的新型复合益生菌多糖胶及其应用
EP3334289B1 (en) 2015-08-14 2019-10-02 Clearh2o, Inc. High throughput process for delivering semi-firm gel for poultry
EP3397278A1 (en) 2015-12-29 2018-11-07 Intervet International B.V. Coccidiosis vaccine
EP3558350A1 (en) * 2016-12-22 2019-10-30 Intervet International B.V. Eimeria vaccine with improved efficacy
HRP20241698T1 (hr) * 2018-11-08 2025-05-09 Biochem Zusatzstoffe Handels- und Produktionsges. mbH Praškasti pripravak i pripravak gela koji sadrže akvatične fotosintetske organizme
CN111330001B (zh) * 2020-03-24 2022-05-20 中国农业大学 一种兔球虫病减毒活疫苗助悬剂及悬浮液
FR3168165A1 (fr) 2024-11-07 2026-05-08 Ceva Sante Animale Suspensions polymeriques et compositions les comprenant pour vacciner la volaille

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1204057A (en) * 1982-06-22 1986-05-06 Eng-Hong Lee Immunization against coccidiosis
US5985336A (en) * 1995-06-07 1999-11-16 Novus International, Inc. Nutrient formulation and process for feeding young poultry and other animals
AU2002327338A1 (en) * 2001-07-25 2003-02-17 New York University Use of glycosylceramides as adjuvants for vaccines against infections and cancer
KR100485145B1 (ko) * 2002-06-03 2005-04-25 윤정민 식용잉크 조성물
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
CA2416726A1 (en) * 2003-01-20 2004-07-20 Eng-Hong Lee Soft gel vaccine delivery system for treating poultry
US20070059346A1 (en) * 2003-07-01 2007-03-15 Todd Maibach Film comprising therapeutic agents
CN1829490A (zh) * 2003-07-01 2006-09-06 托德·迈巴赫 包含治疗剂的薄膜
US20050095336A1 (en) * 2003-11-04 2005-05-05 Pete Maletto Low carbohydrate ice cream
CA2464522C (en) 2004-04-15 2011-11-15 Eng-Hong Lee Soft gel delivery system for treating poultry
EP1757268B1 (en) * 2004-06-07 2017-07-05 Kureha Corporation Dry-form composition for oral ingestion and gel-form composition for oral ingestion of type prepared at time of use
DE102006044447B4 (de) * 2006-09-14 2013-06-20 Manfred Helms Gelartiges Basenpräparat auf Basis ätherischer Ölmischungen zur dermalen und transdermalen Anwendung
JP4913537B2 (ja) * 2006-10-20 2012-04-11 青葉化成株式会社 食品用しみ込み抑制剤、粘性食品および浸透性食品
KR100853301B1 (ko) * 2007-04-13 2008-08-21 주식회사 제닉 이수 방지 기능을 갖는 하이드로겔 조성물 및 이를포함하는 성형체
MX2010008038A (es) * 2008-01-28 2010-08-30 Archer Daniels Midland Co Composiciones para alimentar animales.

Also Published As

Publication number Publication date
US8900623B2 (en) 2014-12-02
PT2459222T (pt) 2017-06-26
EG26998A (en) 2015-03-22
BR112012001938A2 (pt) 2016-03-15
HUE033213T2 (hu) 2017-11-28
CA2769223C (en) 2015-03-17
EP2459222A1 (en) 2012-06-06
EA201270201A1 (ru) 2012-07-30
CA2769223A1 (en) 2011-02-03
BR112012001938B1 (pt) 2020-05-05
CN102481371A (zh) 2012-05-30
EP2459222B1 (en) 2017-03-15
EP2459222A4 (en) 2012-12-26
BR112012001938A8 (pt) 2017-09-19
WO2011011873A1 (en) 2011-02-03
US20120121644A1 (en) 2012-05-17
PL2459222T3 (pl) 2017-09-29
ZA201201009B (en) 2012-10-31
ES2628452T3 (es) 2017-08-02
CN102481371B (zh) 2014-04-16
EA024592B1 (ru) 2016-10-31

Similar Documents

Publication Publication Date Title
EA201270201A1 (ru) Липкий мягкий гель для обработки домашних птиц
BR112017005316A2 (pt) propante revestido e infundido contendo agente de tratamento químico e processos de uso do mesmo
CL2008001194A1 (es) Composicion farmaceutica que comprende florfenico, una ciclodextrina y agua, un solvente y7o una mezcka de los mismos, con al menos 5% de solvente; kit que la contiene; complejo de florfenicol, util para tratr enfermedades respiratorias en animales
UY31305A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen.
CL2013002210A1 (es) Formulación prebiótica para consumo humano que comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, en que la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa; y método para modular o estimular la proliferación de bifidobacterias en el intestino humano.
BRPI0911031B8 (pt) compostos de piperidina ligada do tipo quinoxalina substituídos e os usos destes
EP2395834A4 (en) Sodium nitrite-containing pharmaceutical compositions
EA201001283A1 (ru) Комбинация витамина d и 25-гидроксивитамина d3
CL2013001136A1 (es) Un agente inhibitorio de la fosfodiesterasa 7 (pde7) para ser usado en el tratamiento o la reduccion de la posibilidad de una adiccion; y composicion farmaceutica, forma de dosificacion unitaria y kit farmaceutico que incluyen al inhibidor de fosfodiesterasa 7 (pde7) y un agente terapeutico adicional.
RU2020121715A (ru) Синтез эластического волокна in vivo
CL2008003261A1 (es) Composición farmaceutica en forma de suspension que comprende carisbamato, hipromelosa y agua; proceso para prepararla y su uso para tratar enfermedades tales como epilepsia, dolor neuropatico, temblor y esquizofrenia, entre otras.
BR112015017490A2 (pt) uso de nanopartículas inorgânicas
CL2012002115A1 (es) Una pastilla blanda que comprende nicotina, gelificante, platificante, edulcorante, agente liberador, conservante, saborizante, agua y es capaz de disolverse en la cavidad bucal en un periodo de 5 y 15 minutos; y proceso de preparacion.
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
AR100329A1 (es) Composición y método para el cuidado oral
BR112016029996A2 (pt) utilização cosmética, composição e método cosmético para tratar os odores corporais
GT201400027A (es) Acuosa suspensión concentrada que comprende un ácido sal de dodecilguanidina
AR052855A1 (es) Composiciones para el cuidado bucal que contienen un extrato de eucalyptus
NO20062739L (no) Kontrollert frigivining av topirimat i flytende doseringsform
MX2011007957A (es) Composiciones de acabado mate para la piel.
BR112012010964A2 (pt) uso de composições contendo luteína para melhorar certos aspectos da memória
BR112013016554A2 (pt) métodos e composições úteis para promover sono nos animais
AR083166A1 (es) Derivados de alquil-piperazin-fenil 4(3h)-quinazolinonas utiles para tratar depresion, ansiedad, disfunciones sexuales femeninas y otras patologias del sistema nervioso central, y composiciones farmaceuticas que los contienen
ES2723778T3 (es) Terapia dirigida a células madre cancerosas y contra cáncer resistente a fármacos
AR073133A1 (es) Agente para el tratamiento de enfermedades pulmonares

Legal Events

Date Code Title Description
FG Grant, registration